B. Chi, M. Sinkala, E. Stringer, R. Cantrell, V. Mtonga et al., Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine, AIDS, vol.21, issue.8, pp.957-964, 2007.
DOI : 10.1097/QAD.0b013e32810996b2

P. Coffie, D. Ekouevi, M. Chaix, B. Tonwe-gold, A. Clarisse et al., Maternal 12-Month Response to Antiretroviral Therapy following Prevention of Mother-to-Child Transmission of HIV Type 1, Ivory Coast, 2003- 2006, Clinical Infectious Diseases, vol.46, issue.4, pp.611-621, 2003.
DOI : 10.1086/526780
URL : https://hal.archives-ouvertes.fr/inserm-00179243

G. Jourdain, N. Ngo-giang-huong, L. Coeur, S. Bowonwatanuwong, C. Kantipong et al., Perinatal HIV Prevention Trial Group: Intrapartum exposure to Ekouevi et al http://www.jiasociety.org/content/13/1/28 nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy, Journal of the International AIDS Society N Engl J Med, vol.13, issue.3513, pp.28229-240, 2004.

S. Lockman, R. Shapiro, L. Smeaton, C. Wester, I. Thior et al., Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine, New England Journal of Medicine, vol.356, issue.2, pp.135-147, 2007.
DOI : 10.1056/NEJMoa062876

H. World and . Organization, Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Recommendations for a public health approach, p.26, 2006.

J. Stringer, M. Mcconnell, J. Kiarie, O. Bolu, T. Anekthananon et al., Effectiveness of Non-nucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Women Previously Exposed to a Single Intrapartum Dose of Nevirapine: A Multi-country, Prospective Cohort Study, PLoS Medicine, vol.362, issue.2, p.1000233, 2010.
DOI : 10.1371/journal.pmed.1000233.t005

M. Chaix, D. Ekouevi, G. Peytavin, F. Rouet, B. Tonwe-gold et al., Impact of Nevirapine (NVP) Plasma Concentration on Selection of Resistant Virus in Mothers Who Received Single-Dose NVP To Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission and Persistence of Resistant Virus in Their Infected Children, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.51896-901, 2007.
DOI : 10.1128/AAC.00910-06

S. Eshleman, M. Mracna, L. Guay, M. Deseyve, S. Cunningham et al., Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012), AIDS, vol.15, issue.15, pp.151951-1957, 2001.
DOI : 10.1097/00002030-200110190-00006

M. Pujades-rodriguez, O. Brien, D. Humblet, P. Calmy, and A. , Second-line antiretroviral therapy in resource-limited settings: the experience of M??decins Sans Fronti??res, AIDS, vol.22, issue.11, pp.1305-1312, 2008.
DOI : 10.1097/QAD.0b013e3282fa75b9

A. Calmy, N. Ford, B. Hirschel, S. Reynolds, L. Lynen et al., HIV Viral Load Monitoring in Resource???Limited Regions: Optional or Necessary?, Clinical Infectious Diseases, vol.44, issue.1, pp.128-134, 2007.
DOI : 10.1086/510073

S. Reynolds, G. Nakigozi, K. Newell, A. Ndyanabo, R. Galiwongo et al., Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda, AIDS, vol.23, issue.6, pp.697-700, 2009.
DOI : 10.1097/QAD.0b013e3283262a78

B. Tonwe-gold, D. Ekouevi, C. Bosse, S. Toure, M. Kone et al., Implementing family-focused HIV care and treatment: the first 2???years??? experience of the mother-to-child transmission -plus program in Abidjan, C??te d???Ivoire, Tropical Medicine & International Health, vol.4, issue.2, pp.204-212, 2009.
DOI : 10.1111/j.1365-3156.2008.02182.x

S. Rosen, M. Fox, and C. Gill, Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review, PLoS Medicine, vol.44, issue.10, p.298, 2007.
DOI : 10.1371/journal.pmed.0040298.sd001